FDA grants IDE to RTI Surgical for breast reconstruction device trial
The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) to RTI Surgical’s allograft dermis, opening the…
The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) to RTI Surgical’s allograft dermis, opening the…
The US Food and Drug Administration (FDA) has cleared BrainSpec’s magnetic resonance spectroscopy (MRS) platform, meaning clinicians will now have access to the artificial intelligence (AI)-powered software that measures brain…
GE HealthCare is exhibiting more than 40 new innovations during the Radiological Society of North America’s (RSNA) Annual Meeting in Chicago, 26-30 November 2023. The range of innovations aim to address…
Home-based healthcare provider, Cera, has committed to saving the UK’s National Health Service (NHS) £100m ($126m) using virtual consultations employing artificial intelligence (AI) to reduce hospitalisations. The telehealth app has…
Roche has launched a qualitative and quantitative immunoassay, Elecsys HBeAg quant, to diagnose and monitor hepatitis B. The test can detect the presence of hepatitis B e antigen (HBeAg) in…
SHL Telemedicine is launching a membership programme in the US for its SmartHeart device to treat post-myocardial infarction (MI) patients. SmartHeart is a battery-powered device with a 12-lead electrocardiogram (ECG)…
OrbusNeich Medical Group Holdings, through its wholly owned subsidiary, has acquired an 84% stake in Indonesian distributor PT Revass Utama Medika. The initial estimated amount for this deal is $15.12m.…